Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Kildebeck

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Neurologic Clinics|July 23, 2016
Neurotherapeutic Strategies for Multiple SclerosisTeresa C Frohman, Shin C Beh, Eric J Kildebeck, et al.
Cell Reports|April 2, 2014
Quantifying genome-editing outcomes at endogenous loci with SMRT sequencingAyal Hendel, Eric J Kildebeck, Eli J Fine, et al.
Molecular Therapy. Nucleic Acids|May 2, 2013
Expanding the Repertoire of Target Sites for Zinc Finger Nuclease-mediated Genome ModificationKimberly A Wilson, Abbye E McEwen, Shondra M Pruett-Miller, et al.
Iscience|May 28, 2019
CRISPR/Cas9 Genome Engineering in Engraftable Human Brain-Derived Neural Stem CellsDaniel P Dever, Samantha G Scharenberg, Joab Camarena, et al.
Nature Communications|April 11, 2019
Gene correction for SCID-X1 in long-term hematopoietic stem cellsMara Pavel-Dinu, Volker Wiebking, Beruh T Dejene, et al.
Nature Communications|December 5, 2019
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cellsMara Pavel-Dinu, Volker Wiebking, Beruh T Dejene, et al.
Nature Communications|April 28, 2019
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cellsMara Pavel-Dinu, Volker Wiebking, Beruh T Dejene, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Neurologic Clinics|July 23, 2016
Neurotherapeutic Strategies for Multiple SclerosisTeresa C Frohman, Shin C Beh, Eric J Kildebeck, et al.
Cell Reports|April 2, 2014
Quantifying genome-editing outcomes at endogenous loci with SMRT sequencingAyal Hendel, Eric J Kildebeck, Eli J Fine, et al.
Molecular Therapy. Nucleic Acids|May 2, 2013
Expanding the Repertoire of Target Sites for Zinc Finger Nuclease-mediated Genome ModificationKimberly A Wilson, Abbye E McEwen, Shondra M Pruett-Miller, et al.
Iscience|May 28, 2019
CRISPR/Cas9 Genome Engineering in Engraftable Human Brain-Derived Neural Stem CellsDaniel P Dever, Samantha G Scharenberg, Joab Camarena, et al.
Nature Communications|April 11, 2019
Gene correction for SCID-X1 in long-term hematopoietic stem cellsMara Pavel-Dinu, Volker Wiebking, Beruh T Dejene, et al.
Nature Communications|December 5, 2019
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cellsMara Pavel-Dinu, Volker Wiebking, Beruh T Dejene, et al.
Nature Communications|April 28, 2019
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cellsMara Pavel-Dinu, Volker Wiebking, Beruh T Dejene, et al.
Pageof 1